1-anilino-8-naphthalenesulfonate has been researched along with Hepatitis, Autoimmune in 3 studies
1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.
Hepatitis, Autoimmune: A chronic self-perpetuating hepatocellular INFLAMMATION of unknown cause, usually with HYPERGAMMAGLOBULINEMIA and serum AUTOANTIBODIES.
Excerpt | Relevance | Reference |
---|---|---|
"Fibrosis progression in autoimmune hepatitis can be attenuated by immunosuppressive treatment; however, some patients progress despite therapy." | 1.56 | The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. ( Großhennig, A; Kirstein, MM; Manns, MP; Marhenke, S; Mederacke, I; Mederacke, YS; Metzler, F; Vogel, A, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Mederacke, YS | 2 |
Kirstein, MM | 1 |
Großhennig, A | 1 |
Marhenke, S | 1 |
Metzler, F | 1 |
Manns, MP | 1 |
Vogel, A | 1 |
Mederacke, I | 2 |
Huang, JF | 1 |
Chuang, WL | 1 |
3 other studies available for 1-anilino-8-naphthalenesulfonate and Hepatitis, Autoimmune
Article | Year |
---|---|
The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Disease Progression; Female; Follow-Up Studies; Ge | 2020 |
Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease. Authors' reply.
Topics: Genotype; Hepatitis, Autoimmune; Humans; Lipase; Non-alcoholic Fatty Liver Disease; Prognosis | 2020 |
Editorial: PNPLA3 genotype and liver diseases-more than non-alcoholic fatty liver disease.
Topics: Genotype; Hepatitis, Autoimmune; Humans; Lipase; Non-alcoholic Fatty Liver Disease; Prognosis | 2020 |